INFLUENZA A VIRUS NEURAMINIDASE LIMITS VIRAL SUPERINFECTION
Harvard Medical School, Boston MA
Investigators
Linked publications & trials
Abstract
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Enveloped viruses have multiple mechanisms by which they inhibit infection of a target cell by more than one virion. Here we investigate the ability of influenza A virus hemagglutinin (HA), neuraminidase (NA), and M2 protein pumps to block entry of HA-pseudotyped retroviruses and infectious H1N1 and H3N2 influenza A viruses. We observed that NA from multiple isolates, but not HA or M2 or an enzymatically inactive form of NA, inhibited viral superinfection. Superinfection was markedly increased in the presence of the neuraminidase inhibitors oseltamivir carboxylate and zanamivir. These inhibitors also prevented removal of alpha-2,3- and alpha-2,6-linked sialic acid (SA) observed in cells expressing NA or infected with influenza A viruses. Our data show that the efficiency of SA digestion by NA can regulate viral superinfection, and suggest a functional role for cell-associated NA.
View original record on NIH RePORTER →